Literature DB >> 15037663

Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis.

Matilde E Lleonart1, Santiago Ramón y Cajal, John D Groopman, Marlin D Friesen.   

Abstract

Short oligonucleotide mass analysis (SOMA) is a technique by which small sequences of mutated and wild-type DNA, produced by PCR amplification and restriction digestion, are characterized by HPLC-electrospray ionization tandem mass spectrometry. We have adapted the method to specifically detect two common point mutations at codon 12 of the c-K-ras gene. Mutations in DNA from 121 colon tumor samples were identified by SOMA and validated by comparison with sequencing. SOMA correctly identified 26 samples containing the 12GAT mutation and four samples containing the 12AGT mutation. Sequencing did not reveal mutant DNA in three samples out of the 26 samples shown by SOMA to contain the 12GAT mutation. In these three samples, the presence of mutant DNA was confirmed by SOMA analysis after selective PCR amplification in the presence of BstN1 restriction enzyme. Additional mutations in codons 12 and 13 were revealed by sequencing in 24 additional samples, and their presence did not interfere with the correct identification of G to A or G to T mutations in codon 12. These results provide the basis for a sensitive and specific method to detect c-K-ras codon 12-mutated DNA at levels below 10-12% of wild-type DNA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037663      PMCID: PMC390351          DOI: 10.1093/nar/gnh051

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP.

Authors:  Geng-Sun Qian; Shuang-Yuan Kuang; Xia He; John D Groopman; Peta E Jackson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-10       Impact factor: 4.254

2.  Electrospray ionization quadrupole time-of-flight mass spectrometry and quadrupole mass spectrometry for genotyping single nucleotide substitutions in intact polymerase chain reaction products in K-ras and p53.

Authors:  Warees T Muhammad; Karen F Fox; Alvin Fox; William Cotham; Michael Walla
Journal:  Rapid Commun Mass Spectrom       Date:  2002       Impact factor: 2.419

3.  Analysis of K-ras codon 12 mutation in flat and nodular variants of serrated adenoma in the colon.

Authors:  Yoshifumi Higashidani; Satoru Tamura; Tomoko Morita; Takehisa Tadokoro; Yuichi Yokoyama; Jun-ichi Miyazaki; Yang Yang; Seisho Takeuchi; Hirokuni Taguchi; Saburo Onishi
Journal:  Dis Colon Rectum       Date:  2003-03       Impact factor: 4.585

4.  Molecular diagnosis of familial adenomatous polyposis (FAP): genotyping of adenomatous polyposis coli (APC) alleles by MALDI-TOF mass spectrometry.

Authors:  Thomas Bonk; Andreas Humeny; Christian Sutter; Johannes Gebert; Magnus von Knebel Doeberitz; Cord-Michael Becker
Journal:  Clin Biochem       Date:  2002-03       Impact factor: 3.281

5.  Preferential DNA damage and poor repair determine ras gene mutational hotspot in human cancer.

Authors:  Zhaohui Feng; Wenwei Hu; James X Chen; Annie Pao; Haiying Li; William Rom; Mien-Chie Hung; Moon-shong Tang
Journal:  J Natl Cancer Inst       Date:  2002-10-16       Impact factor: 13.506

6.  Detecting colorectal cancer in stool with the use of multiple genetic targets.

Authors:  S M Dong; G Traverso; C Johnson; L Geng; R Favis; K Boynton; K Hibi; S N Goodman; M D'Allessio; P Paty; S R Hamilton; D Sidransky; F Barany; B Levin; A Shuber; K W Kinzler; B Vogelstein; J Jen
Journal:  J Natl Cancer Inst       Date:  2001-06-06       Impact factor: 13.506

Review 7.  Blocking oncogenic Ras signaling for cancer therapy.

Authors:  A A Adjei
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

8.  Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.

Authors:  Marco Niedergethmann; Martin Rexin; Ralf Hildenbrand; Stefanie Knob; Jörg W Sturm; Axel Richter; Stefan Post
Journal:  Am J Surg Pathol       Date:  2002-12       Impact factor: 6.394

9.  Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice.

Authors:  Sílvia Guerrero; Agnès Figueras; Isolda Casanova; Lourdes Farré; Belen Lloveras; Gabriel Capellà; Manuel Trias; Ramon Mangues
Journal:  FASEB J       Date:  2002-08-07       Impact factor: 5.191

10.  Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.

Authors:  V Bazan; M Migliavacca; I Zanna; C Tubiolo; N Grassi; M A Latteri; M La Farina; I Albanese; G Dardanoni; S Salerno; R M Tomasino; R Labianca; N Gebbia; A Russo
Journal:  Ann Oncol       Date:  2002-09       Impact factor: 32.976

View more
  6 in total

1.  KRAS assay selection: sensitivity and accuracy in clinical application.

Authors:  Marta Herreros-Villanueva; Gaurav Aggarwal
Journal:  Mol Biol Rep       Date:  2011-06-09       Impact factor: 2.316

Review 2.  Genetic and epigenetic biomarkers in cancer : improving diagnosis, risk assessment, and disease stratification.

Authors:  Mukesh Verma; Daniela Seminara; Fernando J Arena; Christy John; Kumiko Iwamoto; Virginia Hartmuller
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

3.  Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.

Authors:  Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Liying Yan; Mami Cantor; Chungdak Namgyal; Mari Mino-Kenudson; Gregory Y Lauwers; Massimo Loda; Charles S Fuchs
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

4.  Detection of rare mutant K-ras DNA in a single-tube reaction using peptide nucleic acid as both PCR clamp and sensor probe.

Authors:  Ji-Dung Luo; Err-Cheng Chan; Chun-Liang Shih; Tai-Long Chen; Ying Liang; Tsann-Long Hwang; Chiuan-Chian Chiou
Journal:  Nucleic Acids Res       Date:  2006-01-23       Impact factor: 16.971

5.  High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer.

Authors:  Michael Krypuy; Genni M Newnham; David M Thomas; Matthew Conron; Alexander Dobrovic
Journal:  BMC Cancer       Date:  2006-12-21       Impact factor: 4.430

6.  Fast simultaneous detection of K-RAS mutations in colorectal cancer.

Authors:  Ya-Sian Chang; Kun-Tu Yeh; Tien-Jye Chang; Connie Chai; Hsiu-Chin Lu; Nicholas C Hsu; Jan-Gowth Chang
Journal:  BMC Cancer       Date:  2009-06-11       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.